501.V2 variant
The 501Y.V2 variant, also known as South African COVID-19 variant, is a variant of the SARS-CoV-2, the virus that causes COVID-19. It is one of several SARS-CoV-2 variants. It was first detected in the Nelson Mandela Bay[1] metropolitan area of the Eastern Cape province of South Africa.
On 23 December 2020, the United Kingdom health minister Matt Hancock said that two people who had travelled from South Africa to the United Kingdom were infected with the 501.V2.[2] On 28 December, the variant was detected in two people in Switzerland[3] and one in Finland.[4]
The United States reported its first cases of the variant in the U.S. state of South Carolina.[5]
501.V2 Variant Media
Countries with confirmed cases of Beta variant as of 2 July 2021Legend:* 1,000+ confirmed sequences* 250–999 confirmed sequences* 100–249 confirmed sequences* 10–99 confirmed sequences* 2–9 confirmed sequences* 1 confirmed sequence* None or no data available
BioNTech vaccine Pfizer BioNTech COVID-19 vaccine.
Amino acid mutations of SARS-CoV-2 Beta variant plotted on a genome map of SARS-CoV-2 with a focus on Spike.
References
- ↑ "SA Reaches Grim Milestone of 1 Million Covid-19 Cases". IOL. Retrieved February 11, 2021.
- ↑ "South African Covid-19 Variant Has Reached the UK". The Guardian. 23 December 2020. Retrieved February 11, 2021.
- ↑ "South African Covid Variant Discovered in Switzerland". Business Insider. Retrieved February 11, 2021.
- ↑ "New UK and South African Covid Strains Detected in Finland". Uutiset. Retrieved February 11, 2021.
- ↑ Chappell, Bill (28 January 2021). "South Carolina Reports 1st Known U.S. Cases from South Africa". NPR. National Public Radio. Retrieved February 11, 2021.
